TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15080859

Group type: EXPERIMENTAL
Intervention: Amphetamine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no amphetamine)
Number of subjects: 0
Study: 12224053

Group type: EXPERIMENTAL
Intervention: Electrical stimulation
Number of subjects: 5

Group type: COMPARATOR
Intervention: Control (no electrical stimulation)
Number of subjects: 5
Study: 9577947

Group type: EXPERIMENTAL
Intervention: Noninvasive baroreflex sensitivity tests (alpha-index and sequence analysis)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Phenylephrine method
Number of subjects: 52
Study: 7664702

Group type: EXPERIMENTAL
Intervention: Propofol 0.6 mg/kg
Number of subjects: 90

Group type: COMPARATOR
Intervention: Midazolam 0.06 mg/kg
Number of subjects: 90
Study: 2539829

Group type: EXPERIMENTAL
Intervention: n-3 fatty acids
Number of subjects: 0
Study: 637999

Group type: EXPERIMENTAL
Intervention: Halothane anaesthesia with FIO2 values of 0.33, 0.5, and 0.75
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Trichloroethylene anaesthesia with FIO2 values of 0.33, 0.5, and 0.75
Number of subjects: 20
Study: 31455099

Group type: EXPERIMENTAL
Intervention: Self-reported emotional eating using the DEBQ
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Self-reported emotional eating using the EES (original and revised versions)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Neutral mood induction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Negative mood induction
Number of subjects: 0
Study: 31011263

Group type: EXPERIMENTAL
Intervention: Mother's knowledge on optimal complementary feeding (AOR=5.4, 95%CI: 2.7, 11)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Postnatal care service utilization (AOR=3.4, 95%CI: 1.7, 7)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Household food security (AOR=5, 95%CI: 2.5, 10.5)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Optimal complementary feeding practices
Number of subjects: 0
Study: 28506854

Group type: COMPARATOR
Intervention: Solifenacin oral suspension
Number of subjects: 148
Study: 26089677

Group type: EXPERIMENTAL
Intervention: Achieved blood pressure goal SBP ≤125 mmHg
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Achieved blood pressure goal SBP ≤140 mmHg
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Achieved blood pressure goal SBP ≤160 mmHg
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: SBP reduction of ≥10 mmHg
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: DBP reduction of ≥5 mmHg
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Cognitive test performances associated with blood pressure goals
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Diagnoses of MCI or dementia associated with blood pressure goals
Number of subjects: 166
Study: 22696494

Group type: EXPERIMENTAL
Intervention: LA fractional change
Number of subjects: 199

Group type: COMPARATOR
Intervention: LAmax, LAmin, LA passive fraction
Number of subjects: 199
Study: 21804501

Group type: EXPERIMENTAL
Intervention: S. boulardii 250 mg twice daily orally for one month
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 19370040

Group type: EXPERIMENTAL
Intervention: Zinc supplementation
Number of subjects: 195
Study: 16720672

Group type: EXPERIMENTAL
Intervention: Ultrasound guidance for epidural catheter placement
Number of subjects: 64

Group type: COMPARATOR
Intervention: Loss-of-resistance (LOR) technique for epidural catheter placement
Number of subjects: 64
Study: 15142153

Group type: EXPERIMENTAL
Intervention: Oxybutynin
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: Tolterodine
Number of subjects: 293

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 293
Study: 11294478

Group type: EXPERIMENTAL
Intervention: Long-term lithium treatment (>6 months)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Short-term lithium treatment (<6 months)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (healthy males)
Number of subjects: 52
Study: 9597415

Group type: EXPERIMENTAL
Intervention: Congenital heart disease adults
Number of subjects: 166
Study: 3620755

Group type: EXPERIMENTAL
Intervention: High-frequency emphasis hearing aid
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional, flatter response aid
Number of subjects: 0
Study: 29684148

Group type: EXPERIMENTAL
Intervention: JNJ‐53718678 75 mg
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: JNJ‐53718678 200 mg
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: JNJ‐53718678 500 mg
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: JNJ‐53718678 (all doses)
Number of subjects: 69
Study: 27543643

Group type: EXPERIMENTAL
Intervention: Fermented milk containing multiple probiotic strains and prebiotic fiber
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 24705147

Group type: EXPERIMENTAL
Intervention: 5-fluorouracil/leucovorin (5-FU/LV)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: capecitabine (CA)
Number of subjects: 60
Study: 22573470

Group type: EXPERIMENTAL
Intervention: ENABLE II concurrent oncology palliative care intervention
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Trial participation
Number of subjects: 72
Study: 21914041

Group type: EXPERIMENTAL
Intervention: Lubiprostone (48 μg day(-1) for 14 days)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Lubiprostone
Number of subjects: 62
Study: 18675844

Group type: EXPERIMENTAL
Intervention: Nutrition education program (dietary advice during the first year based on Brazilian national health policy and WHO guidelines)
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: Nutrition education program
Number of subjects: 397
Study: 17023239

Group type: COMPARATOR
Intervention: Heat wrap (prevention study, n=17)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Heat wrap (treatment study, n=16)
Number of subjects: 67
Study: 14605043

Group type: EXPERIMENTAL
Intervention: Tiotropium 18 micro g/d
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study: 11183431

Group type: EXPERIMENTAL
Intervention: Aromatherapy (essential oils: vetivert, bergamot, and geranium)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo (hair conditioner)
Number of subjects: 66
Study: 8981288

Group type: EXPERIMENTAL
Intervention: Fluid Replacement Trial (FR-trial) with water bolus of 3.0 ml kg‐1 body mass pre-exercise and 2.0 ml kg‐1 body mass every 15 min during exercise
Number of subjects: 8

Group type: COMPARATOR
Intervention: No Fluid Ingestion Trial (NF-trial) with no fluid ingested
Number of subjects: 8
Study: 1361309

Group type: EXPERIMENTAL
Intervention: Vecuronium 10 micrograms/kg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Vecuronium 15 micrograms/kg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Atracurium 50 micrograms/kg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Atracurium 75 micrograms/kg
Number of subjects: 60
Study: 3026273

Group type: EXPERIMENTAL
Intervention: Perindopril 4.8 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Perindopril 16 mg
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 31876202

Group type: EXPERIMENTAL
Intervention: Mental tasking during rotary chair testing (RCT)
Number of subjects: 17

Group type: COMPARATOR
Intervention: No mental task during rotary chair testing (RCT)
Number of subjects: 17
Study: 29524029

Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF) palatal bandage
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no PRF bandage)
Number of subjects: 24
Study: 26995802

Group type: EXPERIMENTAL
Intervention: High threat condition
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Low threat condition
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Both conditions
Number of subjects: 134
Study: 24374724

Group type: EXPERIMENTAL
Intervention: Public social pressure
Number of subjects: 158

Group type: COMPARATOR
Intervention: Anonymous setting
Number of subjects: 158

Group type: COMPARATOR
Intervention: Trait prevalence feedback
Number of subjects: 158

Group type: COMPARATOR
Intervention: Weight bias measure
Number of subjects: 158
Study: 22922460

Group type: EXPERIMENTAL
Intervention: Motor Cortex Stimulation (MCS)
Number of subjects: 38
Study: 20605536

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 0
Study: 18511531

Group type: EXPERIMENTAL
Intervention: 250 units botulinum toxin type A (Dysport)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 37
Study: 19092337

Group type: EXPERIMENTAL
Intervention: PPPD with gastric partition (PPPD-GP)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Conventional pancreatojejunostomy (PPPD-PJ)
Number of subjects: 108
Study: 15570642

Group type: EXPERIMENTAL
Intervention: Low level laser therapy
Number of subjects: 48

Group type: COMPARATOR
Intervention: Sham treatment (placebo)
Number of subjects: 48
Study: 11320359

Group type: EXPERIMENTAL
Intervention: Pravastatin therapy
Number of subjects: 0
Study: 9236502

Group type: EXPERIMENTAL
Intervention: Cow milk powder
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo solution
Number of subjects: 25
Study: 8121246

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 3307570

Group type: EXPERIMENTAL
Intervention: Protocol management (PM) group
Number of subjects: 48

Group type: COMPARATOR
Intervention: Routine management (RM) group
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Protocol management (PM) group with initially high EVLW
Number of subjects: 48

Group type: COMPARATOR
Intervention: Both groups with initial EVLW > 14 ml/kg
Number of subjects: 48
Study: 31377713

Group type: EXPERIMENTAL
Intervention: Protocolized post-extubation respiratory support (non-invasive ventilation or high-flow nasal cannula)
Number of subjects: 630

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 630
Study: 28173855

Group type: EXPERIMENTAL
Intervention: Treatment for psychosocial distress
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Screening for psychosocial distress
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Elevated symptoms of psychosocial distress
Number of subjects: 128
Study: 26085529

Group type: EXPERIMENTAL
Intervention: Web-based multimedia tutorial in addition to standard counseling (20-minute duration)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Standard preoperative counseling
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Web-based multimedia tutorial in addition to standard counseling
Number of subjects: 64
Study: 24060199

Group type: EXPERIMENTAL
Intervention: Clinically driven monitoring (CDM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Laboratory and clinical monitoring (LCM)
Number of subjects: 0
Study: 21165641

Group type: EXPERIMENTAL
Intervention: Balance training intervention (six weeks, nine exercises progressed in difficulty)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control conditions (Foam vs. Hard, EO vs. EC)
Number of subjects: 26
Study: 19745564

Group type: EXPERIMENTAL
Intervention: Olmesartan medoxomil
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Azelnidipine
Number of subjects: 29

Group type: COMPARATOR
Intervention: Olmesartan medoxomil and Azelnidipine
Number of subjects: 29
Study: 16940405

Group type: EXPERIMENTAL
Intervention: Oseltamivir 75 mg (single oral dose)
Number of subjects: 12
Study: 15251866

Group type: EXPERIMENTAL
Intervention: T2DM
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: T2DM and Ob
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Ob
Number of subjects: 45
Study: 11502787

Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy/estrogen replacement therapy (conjugated estrogens 0.625 mg daily + medroxyprogesterone acetate 2.5 mg daily)
Number of subjects: 489

Group type: EXPERIMENTAL
Intervention: Calcitriol (0.25 microg twice daily)
Number of subjects: 489

Group type: EXPERIMENTAL
Intervention: Combination of hormone replacement therapy/estrogen replacement therapy + calcitriol
Number of subjects: 489

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 489

Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy/estrogen replacement therapy alone
Number of subjects: 489

Group type: EXPERIMENTAL
Intervention: Calcitriol (in adherent women)
Number of subjects: 489

Group type: EXPERIMENTAL
Intervention: Combination therapy (in adherent women)
Number of subjects: 489
Study: 9415505

Group type: EXPERIMENTAL
Intervention: Ignoring pain sensations
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Coping self statements
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Catastrophizing
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Diverting attention
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Praying or hoping
Number of subjects: 130
Study: 8484558

Group type: EXPERIMENTAL
Intervention: 200 micrograms/kg of mivacurium preceded by 15 micrograms/kg of pancuronium
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 170 micrograms/kg of mivacurium preceded by 15 micrograms/kg of pancuronium
Number of subjects: 48

Group type: COMPARATOR
Intervention: 200 micrograms/kg of mivacurium alone
Number of subjects: 48
Study: 3322468

Group type: EXPERIMENTAL
Intervention: Fluoxetine (mean dose 73 mg each morning)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Amitriptyline (mean dose 122 mg at night)
Number of subjects: 64
Study: 29466533

Group type: EXPERIMENTAL
Intervention: Clinician intervention (workshop and up to 6 coaching calls)
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Clinician coaching sessions (dosage)
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Patient intervention (3-session program)
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Interaction between patient and clinician dosage
Number of subjects: 312

Group type: COMPARATOR
Intervention: Control condition (patient and clinician in control)
Number of subjects: 312

Group type: COMPARATOR
Intervention: Patient in intervention and clinician in control
Number of subjects: 312

Group type: COMPARATOR
Intervention: Patient in control and clinician in intervention
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Patient and clinician in intervention
Number of subjects: 312
Study: 26827293

Group type: EXPERIMENTAL
Intervention: Standard treatment plus practice quitting program (N = 46)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Standard treatment (N = 47)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Practice quitting program (N = 46)
Number of subjects: 93
Study: 23656209

Group type: EXPERIMENTAL
Intervention: 4% articaine with 1 : 100,000 epinephrine
Number of subjects: 50

Group type: COMPARATOR
Intervention: 4% articaine with 1 : 100,000 epinephrine bitartrate
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 50
Study: 22650122

Group type: EXPERIMENTAL
Intervention: Only-puncturing at Dazhong (KI 4) with respiratory reinforcing method
Number of subjects: 126

Group type: COMPARATOR
Intervention: Routine acupuncture therapy at Shenshu (BL 23)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Both groups (Dazhong and routine acupuncture)
Number of subjects: 126
Study: 19924132

Group type: EXPERIMENTAL
Intervention: N-PASS assessment tool during heelstick procedure
Number of subjects: 0

Group type: COMPARATOR
Intervention: N-PASS assessment tool during sham heelstick procedure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: N-PASS assessment tool
Number of subjects: 0
Study: 18399768

Group type: EXPERIMENTAL
Intervention: Iodized oil administered orally
Number of subjects: 364
Study: 16034225

Group type: EXPERIMENTAL
Intervention: Ossur Rheo (variable-damping knee)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Otto Bock C-leg (variable-damping knee)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Mauch SNS (mechanically passive knee)
Number of subjects: 8
Study: 11135715

Group type: EXPERIMENTAL
Intervention: Intramuscular rapacuronium 2.8 mg/kg in infants
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Intramuscular rapacuronium 4.8 mg/kg in children
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Intramuscular rapacuronium (both doses)
Number of subjects: 96
Study: 9820916

Group type: EXPERIMENTAL
Intervention: Early active training program
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (traditional, less active training program)
Number of subjects: 52
Study: 7605424

Group type: EXPERIMENTAL
Intervention: INR system using three thromboplastin reagents
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control patients on warfarin (n = 31)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Fibrinogen, factors V, II and X
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: FDP's
Number of subjects: 29
Study: 2731163

Group type: EXPERIMENTAL
Intervention: Oral supplementation with beta-carotene (90 mg twice weekly for 4 weeks)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 36
Study: 31139989

Group type: EXPERIMENTAL
Intervention: Warm saline
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Anti-fog solution
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Chlorhexidine
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control
Number of subjects: 96
Study: 29739378

Group type: EXPERIMENTAL
Intervention: Serum 25-hydroxyvitamin D concentrations ≥30 ng/ml
Number of subjects: 284

Group type: COMPARATOR
Intervention: Serum 25-hydroxyvitamin D concentrations <30 ng/ml
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: Median serum 25(OH)D concentrations
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: Overall vitamin D deficiency prevalence
Number of subjects: 284
Study: 27271833

Group type: EXPERIMENTAL
Intervention: Interferential currents for psoriasis treatment
Number of subjects: 594

Group type: COMPARATOR
Intervention: Standard medicamentous therapy for psoriasis treatment
Number of subjects: 594

Group type: EXPERIMENTAL
Intervention: Interferential currents for eczema treatment
Number of subjects: 594

Group type: COMPARATOR
Intervention: Standard medicamentous therapy for eczema treatment
Number of subjects: 594
Study: 25331573

Group type: EXPERIMENTAL
Intervention: Antibiotic prescribing
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: Incidence of AAD
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: Co-amoxiclav
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: Incontinence pads usage
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: Residential homes
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: Antibiotic-resistant isolates
Number of subjects: 279
Study: 22633965

Group type: EXPERIMENTAL
Intervention: Retinal vessel movement in eyes with ERM
Number of subjects: 206
Study: 21028985

Group type: EXPERIMENTAL
Intervention: High-dose artesunate therapy (4 mg/kg/day orally for 7 days)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Quinine-tetracycline
Number of subjects: 94
Study: 18402857

Group type: EXPERIMENTAL
Intervention: Ropivacaine
Number of subjects: 114

Group type: COMPARATOR
Intervention: Lidocaine
Number of subjects: 114
Study: 15811479

Group type: EXPERIMENTAL
Intervention: Manidipine 10 mg once daily for 24 weeks
Number of subjects: 111

Group type: COMPARATOR
Intervention: Enalapril 10 mg once daily for 24 weeks
Number of subjects: 111
Study: 12219857

Group type: EXPERIMENTAL
Intervention: Social exclusion feedback (telling individuals they are likely to end up alone later in life)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Social exclusion feedback
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group feedback (telling individuals their future would be marred by frequent accidents)
Number of subjects: 0
Study: 11224967

Group type: EXPERIMENTAL
Intervention: Standard therapist contact
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Minimum therapist contact
Number of subjects: 104

Group type: COMPARATOR
Intervention: Bibliotherapy
Number of subjects: 104
Study: 8974213

Group type: EXPERIMENTAL
Intervention: Fluvastatin therapy (20 mg twice daily)
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: Open-label adjunctive cholestyramine (for patients with mean prerandomization LDL cholesterol of 160 mg/dL or higher)
Number of subjects: 429

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 429
Study: 14621733

Group type: EXPERIMENTAL
Intervention: Calcium antagonists (CATs)
Number of subjects: 0
Study: 3830764

Group type: EXPERIMENTAL
Intervention: Diltiazem 120 mg every 8 hours for three consecutive days
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo administered with the same regimen
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 20
Study: 30819640

Group type: EXPERIMENTAL
Intervention: Pharmacist-provided medication therapy management program
Number of subjects: 400

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 400
Study: 29580132

Group type: EXPERIMENTAL
Intervention: Physical activity group (P); moderate to vigorous exercise (20 min, 3 times per week, 6 weeks) while learning times tables
Number of subjects: 85

Group type: COMPARATOR
Intervention: Control group (C); seated classroom approach while learning times tables
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Physical activity group (P)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 85
Study: 26962396

Group type: EXPERIMENTAL
Intervention: Snello cookie (HFHCM‐S)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control cookies (HFHCM‐C)
Number of subjects: 10
Study: 24548353

Group type: EXPERIMENTAL
Intervention: Traffic light bougie
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional bougie
Number of subjects: 40
Study: 22317945

Group type: EXPERIMENTAL
Intervention: 5 mg zolpidem
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 10 mg zolpidem
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 20122433

Group type: EXPERIMENTAL
Intervention: Midpalatal miniscrews
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Midpalatal miniscrews with splinting
Number of subjects: 128
Study: 18269774

Group type: EXPERIMENTAL
Intervention: Albumin-bound paclitaxel 100 mg/m2
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Albumin-bound paclitaxel 125 mg/m2
Number of subjects: 181